# To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

> **NCT01070043** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 60 (actual)

## Conditions studied

- Hypertension
- High Blood Pressure

## Interventions

- **DRUG:** Amlodipine 5mg/Valsartan 80 mg
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT01070043
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01070043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01070043, "To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01070043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*